HIGHLY significant growth responses in the rudimentary mammary glands of intact weanling male mice of the S.A.S.3 strain have been induced by pituitary prolactin when administered twice daily for five days by subcutaneous injection (Hadfield and Young, 1956). Compared with the responses produced by oestrone in the same strain at various dose levels over the same short period of injection, the mammae of prolactin-treated weanling males showed a significantly greater degree of glandular differentiation with the production of easily recognisable acini. Both hormones induced rapid development of the mammary ducts and ductules.
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During the last two years, and until a few months ago, we have injected, twice daily for five days, a large number of specimens of human female urine into male weanlings of the S.A.S.3 strain, no other strain being used. Unmistakable mammary growth reactions have been obtained with the majority of urine specimens and these show the same degree of duct development and glandular differentiation which characterises the weanling mammae reacting to prolactin. Similar reactions to urine were obtained when specimens from normal premenopausal women in the post-ovulatory phase of menstruation were used, and significant responses were induced by the urine of 57 per cent of postmenopausal women.
Some months ago the mammary glands of the weanling males of the S.A.S.3 strain showed a precipitate fall in their ability to react both to prolactin and to human female urine (this has since returned). An extensive search was therefore made for another strain whose weanling males are sensitive to prolactin and urine.
This has proved successful but the enquiry revealed the disconcerting fact that in the large majority of common strains of laboratory mice the mammary glands of the weanling males are quite unresponsive to prolactin and that this characteristic always appears to be associated with complete mammary insensitivity to human female urine. This observation explains the failure of several workers to confirm our published experiments which demnonstrated the mammogenic property of human female urine when the "sensitive" mamma of S.A.S.3 weanling males was used as the "indicator ".
Other relevant facts have emerged from this enquiry. They throw some light on the nature of the mammotrophic hormone present in the urine of normal women and the present paper is a record of experiments dealing with these problems. METHODS For each experiment five or more weanling males, aged 25 days on the day of the first injection, were used. They were given 0.2 ml. twice a day for a period of five days, of the untreated urine of normal pre-menopausal women in the second half of the menstrual cycle, or 0.1 ml. of oestrone or 0.1 ml. of prolactin in varying concentrations (see below). The intensity of the mammary response was measured by counting the end-bulbs or clubs in each gland. The yield of mammary glands per weanling was 5 or 6, so each batch of five animals produced about 27 glands.
The average number of clubs per gland is taken to be a reasonably accurate measure of growth response. The average number of clubs per gland in untreated male weanlings in the strains examined was less than 1 in the majority and only fractionally over 1 in the remaining few. Urines proved to be potent failed to produce a significant mammary growth response in any of these 37 strains. Twelve of these strains, including the reacting S.A.S.3 and A2G, were further examined for their ability to react to oestrone and prolactin. The strains were selected because of their popularity as experimental animals and their ready'availability.
Thirty-seven strains, as shown in Table I , have been examined.
Response to urine.-The mammae of A2G mice were found to react vigorously to normal pre-menopausal urine and as the S.A.S.3 mice were found to have regained their previous sensitivity, a batch of weanlings from each of these strains was included in every experiment as controls. This indicated whether the urine was active or not and gave a measure of its potency.
Response tooestrone.-Using oestrone (B.D.H.) dissolved in 50 per cent aqueous propylene glycol, the optimum dose level was determined over a total dose range of 0.001 to 1.0 ,ug. given in ten injections over a period of five days. The latter concentration was selected as giving a typical and vigorous response and oestrone at this level was therefore administered to groups of animals from each of the twelve strains, including A2G and S.A.S.3. Unmistakable mammary growth responses were induced in all strains without exception.
Response to prolactin. 2. Twelve of these strains, including those possessing mammary sensitivity to human pre-menopausal female urine, responded satisfactorily to oestrone; the reaction was confined to the duct system; there was little or no glandular acinisation.
3. Two strains only-S.A.S.3 and A2G-responded to prolactin. In these the response was vigorous and unmistakable and early acinisation was common.
4. Strains responding to prolactin also responded satisfactorily to human female urine.
5. Strains failing to respond to prolactin failed to respond to human female urine.
6. These results support the contention that the mammotrophic agent present in human pre-menopausal female urine is prolactin. STRETTON.-(1956) Brit. J. Cancer, 10, 145, 324. 
